Finch Therapeutics Group Ownership 2024 | Who Owns Finch Therapeutics Group Now?
Institutional Ownership
0.12%
Insider Ownership
53.46%
Retail Ownership
46.43%
Institutional Holders
1.00
Finch Therapeutics Group Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| AVENIR MANAGEMENT COMPANY, LLC | - | - | - | -55,445 | -100.00% | - | Sep 30, 2023 |
Finch Therapeutics Group's largest institutional shareholder is AVENIR MANAGEMENT COMPANY, LLC, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| AVENIR MANAGEMENT COMPANY, LLC | - | - | - | -55,445 | -100.00% | - | Sep 30, 2023 |
The largest Finch Therapeutics Group shareholder by % of total assets is AVENIR MANAGEMENT COMPANY, LLC. The company owns 0.00 shares of Finch Therapeutics Group (FNCH), representing 0.00% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| AVENIR MANAGEMENT COMPANY, LLC | - | - | - | -55,445 | -100.00% | - | Sep 30, 2023 |
As of Sep 30 2023, Finch Therapeutics Group's largest institutional buyer is AVENIR MANAGEMENT COMPANY, LLC. The company purchased -55.45K stocks of FNCH, valued at -.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| AVENIR MANAGEMENT COMPANY, LLC | - | - | - | -55,445 | -100.00% | - | Sep 30, 2023 |
As of Sep 30 2023, Finch Therapeutics Group's biggest institutional seller is AVENIR MANAGEMENT COMPANY, LLC. The company sold -55.45K shares of FNCH, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| AVENIR MANAGEMENT COMPANY, LLC | - | - | - | -55,445 | -100.00% | - | Sep 30, 2023 |
Finch Therapeutics Group's largest sold out institutional shareholder by shares sold is AVENIR MANAGEMENT COMPANY, LLC, sold -55.45K shares, valued at -, as of undefined.
Finch Therapeutics Group Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| Collaborative Investment Series Trust | 1.44% | 224,916 | - | - | Mar 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.07% | 157,667 | - | - | Mar 28, 2024 |
| Collaborative Investment Series Trust | 0.05% | 7,497 | - | - | Mar 31, 2024 |
| Humankind Benefit Corp | 0.04% | 917 | - | - | Dec 31, 2023 |
| VANGUARD VALLEY FORGE FUNDS | 0.04% | 21,220 | - | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 976,826 | - | - | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.00% | 13,935 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.00% | 1,151 | - | - | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 192,129 | - | - | Feb 29, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 18,783 | - | - | Feb 29, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 13,688 | - | - | Mar 31, 2024 |
| Advisors' Inner Circle Fund III | 0.00% | 34,342 | - | - | Jan 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 593 | - | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 36,252 | -18,746 | -34.08% | Mar 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 349 | - | - | Mar 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 152 | - | - | Mar 31, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 31,882 | - | - | Feb 29, 2024 |
| Global X Funds | 0.00% | 2,238 | - | - | Jan 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 6,402 | - | - | Feb 29, 2024 |
| NORTHERN FUNDS | 0.00% | 4,021 | - | - | Mar 28, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 1,831 | - | - | Feb 29, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 1,700 | - | - | Mar 31, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 72 | - | - | Dec 31, 2023 |
| ProFunds | 0.00% | 165 | - | - | Mar 31, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 400 | - | - | Mar 28, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 52,047 | - | - | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 24,688 | - | - | Feb 29, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 40 | - | - | Dec 31, 2023 |
| VALIC Co I | 0.00% | 2,805 | - | - | Feb 29, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 9,937 | - | - | Jan 31, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 1,253 | - | - | Mar 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 205 | - | - | Feb 29, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 1,732 | - | - | Jan 31, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 7,831 | - | - | Mar 31, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 44 | - | - | Feb 29, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 8 | - | - | Dec 31, 2023 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 717 | - | - | Jan 31, 2024 |
| PROSHARES TRUST | 0.00% | 1,097 | - | - | Feb 29, 2024 |
| EQ ADVISORS TRUST | 0.00% | 4,786 | - | - | Mar 31, 2024 |
| TIAA-CREF FUNDS | 0.00% | 11,850 | - | - | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 58,727 | - | - | Mar 31, 2024 |
| Dimensional ETF Trust | 0.00% | 1,383 | - | - | Jan 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 290 | - | - | Feb 29, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 6,500 | - | - | Mar 31, 2024 |
| ETF Series Solutions | 0.00% | 49 | - | - | Jan 31, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 835 | - | - | Mar 31, 2024 |
| PACIFIC SELECT FUND | 0.00% | 3,855 | - | - | Mar 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 686 | - | - | Dec 31, 2023 |
| Bridge Builder Trust | 0.00% | 2,601 | - | - | Mar 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 739 | - | - | Mar 31, 2024 |
| Dimensional ETF Trust | 0.00% | 100 | - | - | Jan 31, 2024 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 903 | - | - | Mar 31, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 1 | - | - | Feb 29, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 124 | - | - | Jan 31, 2024 |
Finch Therapeutics Group's largest mutual fund holder by % of total assets is "Collaborative Investment Series Trust", owning 224.92K shares, compromising 1.44% of its total assets.
Finch Therapeutics Group Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 23 | 1 | -96.77% |
| 31 Mar, 23 | 31 | -13.89% |
| 31 Dec, 22 | 36 | -2.70% |
| 30 Sep, 22 | 37 | -7.50% |
| 30 Jun, 22 | 40 | -23.08% |
| 31 Mar, 22 | 52 | 1.96% |
| 31 Dec, 21 | 51 | 15.91% |
| 30 Sep, 21 | 44 | -2.22% |
| 30 Jun, 21 | 45 | 25.00% |
| 31 Mar, 21 | 36 | - |
As of 30 Jun 23, 1 institutions are holding Finch Therapeutics Group's shares, representing a decrease of -96.77% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 23 | 55,445 | -99.42% |
| 31 Mar, 23 | 9,550,516 | -0.39% |
| 31 Dec, 22 | 9,588,250 | -4.50% |
| 30 Sep, 22 | 10,040,414 | 1.80% |
| 30 Jun, 22 | 9,862,548 | -6.55% |
| 31 Mar, 22 | 10,554,218 | -8.69% |
| 31 Dec, 21 | 11,558,085 | 40.72% |
| 30 Sep, 21 | 8,213,322 | 49.00% |
| 30 Jun, 21 | 5,512,333 | -19.09% |
| 31 Mar, 21 | 6,813,126 | - |
Finch Therapeutics Group (FNCH) has 55.45K shares outstanding as of 30 Jun 23, down -99.42% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 23 | 0.12% | 26.31% |
| 31 Mar, 23 | 0.66% | 148.89% |
| 31 Dec, 22 | 0.67% | 135.62% |
| 30 Sep, 22 | 0.70% | 146.86% |
| 30 Jun, 22 | 0.69% | 126.11% |
| 31 Mar, 22 | 0.74% | 112.48% |
| 31 Dec, 21 | 0.81% | 243.66% |
| 30 Sep, 21 | 0.58% | 383.68% |
| 30 Jun, 21 | 0.39% | 168.81% |
| 31 Mar, 21 | 0.48% | - |
As of 30 Jun 23, Finch Therapeutics Group is held by 0.12% institutional shareholders, representing a 26.31% growth compared to 31 Mar 23.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 23 | - | -100.00% |
| 31 Mar, 23 | 5 | -44.44% |
| 31 Dec, 22 | 9 | -18.18% |
| 30 Sep, 22 | 11 | -35.29% |
| 30 Jun, 22 | 17 | 41.67% |
| 31 Mar, 22 | 12 | -53.85% |
| 31 Dec, 21 | 26 | 8.33% |
| 30 Sep, 21 | 24 | -22.58% |
| 30 Jun, 21 | 31 | -13.89% |
| 31 Mar, 21 | 36 | - |
- institutional shareholders have increased their position in FNCH stock as of 30 Jun 23 compared to 5 in the previous quarter (a -100.00% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 23 | 1 | -88.89% |
| 31 Mar, 23 | 9 | 12.50% |
| 31 Dec, 22 | 8 | -11.11% |
| 30 Sep, 22 | 9 | 12.50% |
| 30 Jun, 22 | 8 | -60.00% |
| 31 Mar, 22 | 20 | 185.71% |
| 31 Dec, 21 | 7 | -30.00% |
| 30 Sep, 21 | 10 | - |
| 30 Jun, 21 | 10 | - |
| 31 Mar, 21 | - | - |
1 institutional shareholders have reduced their position in FNCH stock as of 30 Jun 23 compared to 9 in the previous quarter (a -88.89% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 23 | 1 | -96.77% | 55,445 | -99.42% | 0.12% | 26.31% | - | -100.00% | 1 | -88.89% |
| 31 Mar, 23 | 31 | -13.89% | 9,550,516 | -0.39% | 0.66% | 148.89% | 5 | -44.44% | 9 | 12.50% |
| 31 Dec, 22 | 36 | -2.70% | 9,588,250 | -4.50% | 0.67% | 135.62% | 9 | -18.18% | 8 | -11.11% |
| 30 Sep, 22 | 37 | -7.50% | 10,040,414 | 1.80% | 0.70% | 146.86% | 11 | -35.29% | 9 | 12.50% |
| 30 Jun, 22 | 40 | -23.08% | 9,862,548 | -6.55% | 0.69% | 126.11% | 17 | 41.67% | 8 | -60.00% |
| 31 Mar, 22 | 52 | 1.96% | 10,554,218 | -8.69% | 0.74% | 112.48% | 12 | -53.85% | 20 | 185.71% |
| 31 Dec, 21 | 51 | 15.91% | 11,558,085 | 40.72% | 0.81% | 243.66% | 26 | 8.33% | 7 | -30.00% |
| 30 Sep, 21 | 44 | -2.22% | 8,213,322 | 49.00% | 0.58% | 383.68% | 24 | -22.58% | 10 | - |
| 30 Jun, 21 | 45 | 25.00% | 5,512,333 | -19.09% | 0.39% | 168.81% | 31 | -13.89% | 10 | - |
| 31 Mar, 21 | 36 | - | 6,813,126 | - | 0.48% | - | 36 | - | - | - |
Finch Therapeutics Group Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
All Insider Owners Trades
The last insider sell of Finch Therapeutics Group's stock was made by SMISEK JEFFERY A on Jun 10 2024, selling 383 shares at - per share (valued at -). The last insider buy of FNCH was made by Graf Susan E on Jun 09 2023, buying 5,010 shares at $0.27 per share (worth $1.35K).
Finch Therapeutics Group Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q1 2024 | - | 2 | - |
| Q4 2023 | - | 1 | - |
| Q2 2023 | 9 | - | - |
| Q1 2023 | - | 1 | - |
| Q4 2022 | - | 2 | - |
| Q2 2022 | 13 | - | - |
| Q1 2022 | 3 | - | - |
| Q4 2021 | 3 | - | - |
| Q3 2021 | 1 | - | - |
| Q2 2021 | 2 | - | - |
| Q1 2021 | 23 | 24 | 95.83% |
0 total buy trades, and 2 total sell trades (buy/sell ratio of 0.00%) were made by Finch Therapeutics Group's insiders, as of Q1 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q1 2024 | - | 2 | - |
| Q4 2023 | - | 1 | - |
| Q2 2023 | 1 | - | - |
| Q1 2023 | - | 1 | - |
| Q4 2022 | - | 2 | - |
| Q2 2022 | - | - | - |
| Q1 2022 | - | - | - |
| Q4 2021 | 1 | - | - |
| Q3 2021 | - | - | - |
| Q2 2021 | - | - | - |
| Q1 2021 | 4 | - | - |
As of Q1 2024, Insider owners conducted 0 open market buy trades and 2 open market sell trades of Finch Therapeutics Group's stocks.
Finch Therapeutics Group Peer Ownership
| Ticker | Company |
|---|---|
| NTRB | Nutriband Inc. |
| DBTX | Decibel Therapeutics, Inc. |
| BWV | Onconetix, Inc. |
| IKNA | Ikena Oncology, Inc. |
| EWTX | Edgewise Therapeutics, Inc. |
| STOK | Stoke Therapeutics, Inc. |
| KPRX | Kiora Pharmaceuticals, Inc. |
| LGVN | Longeveron Inc. |
| REVB | Revelation Biosciences, Inc. |
| QNRX | Quoin Pharmaceuticals, Ltd. |
| HILS | Tharimmune, Inc. |
| VRAX | Virax Biolabs Group Limited |
| CCCC | C4 Therapeutics, Inc. |
| GLUE | Monte Rosa Therapeutics, Inc. |
| DSGN | Design Therapeutics, Inc. |
| RNXT | RenovoRx, Inc. |
| HOWL | Werewolf Therapeutics, Inc. |
| XLO | Xilio Therapeutics, Inc. |
| CELC | Celcuity Inc. |
| ELYM | Eliem Therapeutics, Inc. |
FNCH Ownership FAQ
Who Owns Finch Therapeutics Group?
Finch Therapeutics Group is owned by institutional shareholders (0.12%), insiders (53.46%), and public (46.43%). The largest institutional shareholder of Finch Therapeutics Group is AVENIR MANAGEMENT COMPANY, LLC (0% of total shares) and the top mutual fund owner is Collaborative Investment Series Trust (1.44% of total shares).
Who are the major institutional shareholders of Finch Therapeutics Group?
Finch Therapeutics Group's major institutional shareholders are AVENIR MANAGEMENT COMPANY, LLC. The top five shareholders own together 0% of the company's share outstanding.
How many Finch Therapeutics Group shareholders are there?
As of Jun 2023, there are 1 institutional shareholders of Finch Therapeutics Group.
What percentage of Finch Therapeutics Group is owned by AVENIR MANAGEMENT COMPANY, LLC?
AVENIR MANAGEMENT COMPANY, LLC owns 0 shares of Finch Therapeutics Group, representing 0% of the company's total shares outstanding, valued at $0 (as of Sep 2023).